$13.73
Revenue is down for the last 3 quarters, 164.98M → 161.16M (in $), with an average decrease of 1.2% per quarter
Netprofit is up for the last 3 quarters, -84.94M → 21.18M (in $), with an average increase of 470.1% per quarter
In the last 1 year, Welltower Inc. has given 26.1% return, outperforming this stock by 16.2%
In the last 3 years, Welltower Inc. has given 52.3% return, outperforming this stock by 53.1%
0.29%
Downside
Day's Volatility :1.44%
Upside
1.15%
30.23%
Downside
52 Weeks Volatility :33.1%
Upside
4.12%
Period | Sabra Health Care Reit Inc | Sector (Real Estate) | Index (Russel 2000) |
---|---|---|---|
3 Months | 16.03% | -8.5% | 0.0% |
6 Months | 28.5% | -4.2% | 1.0% |
1 Year | 9.91% | -5.8% | 6.4% |
3 Years | -3.2% | -2.2% | 19.9% |
Market Capitalization | 3.2B |
Book Value | $12.73 |
Dividend Share | 1.2 |
Dividend Yield | 8.61% |
Earnings Per Share (EPS) | -0.54 |
PEG Ratio | 3.15 |
Wall Street Target Price | 13.63 |
Profit Margin | -22.77% |
Operating Margin TTM | 23.62% |
Return On Assets TTM | 1.39% |
Return On Equity TTM | -3.94% |
Revenue TTM | 541.5M |
Revenue Per Share TTM | 2.34 |
Quarterly Revenue Growth YOY | 4.6% |
Gross Profit TTM | 372.8M |
EBITDA | 315.6M |
Diluted Eps TTM | -0.54 |
Quarterly Earnings Growth YOY | 0.29 |
EPS Estimate Current Year | 0.31 |
EPS Estimate Next Year | 0.57 |
EPS Estimate Current Quarter | 0.1 |
EPS Estimate Next Quarter | 0.1 |
What analysts predicted
Downside of 0.73%
FY17 | Y/Y Change | |
---|---|---|
Revenue | 405.6M | ↑ 55.7% |
Net Income | 158.4M | ↑ 125.37% |
Net Profit Margin | 39.04% | ↑ 12.07% |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 623.4M | ↑ 53.68% |
Net Income | 279.1M | ↑ 76.21% |
Net Profit Margin | 44.77% | ↑ 5.73% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 661.7M | ↑ 6.15% |
Net Income | 69.0M | ↓ 75.28% |
Net Profit Margin | 10.43% | ↓ 34.34% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 598.6M | ↓ 9.55% |
Net Income | 138.4M | ↑ 100.62% |
Net Profit Margin | 23.12% | ↑ 12.69% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 569.5M | ↓ 4.85% |
Net Income | -113.3M | ↓ 181.82% |
Net Profit Margin | -19.89% | ↓ 43.01% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 624.8M | ↑ 9.7% |
Net Income | -77.6M | ↓ 31.48% |
Net Profit Margin | -12.42% | ↑ 7.47% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 163.1M | ↑ 20.23% |
Net Income | 40.6M | ↓ 266.72% |
Net Profit Margin | 24.89% | ↑ 42.84% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 156.0M | ↓ 4.38% |
Net Income | 16.8M | ↓ 58.61% |
Net Profit Margin | 10.78% | ↓ 14.11% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 140.8M | ↓ 9.74% |
Net Income | -50.1M | ↓ 397.91% |
Net Profit Margin | -35.57% | ↓ 46.35% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 165.0M | ↑ 17.21% |
Net Income | -84.9M | ↑ 69.68% |
Net Profit Margin | -51.49% | ↓ 15.92% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 161.3M | ↓ 2.22% |
Net Income | -9.5M | ↓ 88.83% |
Net Profit Margin | -5.88% | ↑ 45.61% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 161.2M | ↓ 0.1% |
Net Income | 21.2M | ↓ 323.34% |
Net Profit Margin | 13.15% | ↑ 19.03% |
FY17 | Y/Y Change | |
---|---|---|
Total Assets | 7.0B | ↑ 210.35% |
Total Liabilities | 3.6B | ↑ 187.53% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 6.7B | ↓ 5.22% |
Total Liabilities | 3.4B | ↓ 5.13% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 6.1B | ↓ 8.94% |
Total Liabilities | 2.6B | ↓ 24.33% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 6.0B | ↓ 1.38% |
Total Liabilities | 2.6B | ↓ 0.17% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 6.0B | ↓ 0.32% |
Total Liabilities | 2.6B | ↑ 0.42% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 5.7B | ↓ 3.67% |
Total Liabilities | 2.7B | ↑ 4.02% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.9B | ↓ 1.37% |
Total Liabilities | 2.5B | ↓ 2.46% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 6.0B | ↑ 1.3% |
Total Liabilities | 2.6B | ↑ 4.77% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.8B | ↓ 1.95% |
Total Liabilities | 2.6B | ↓ 0.28% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.7B | ↓ 1.66% |
Total Liabilities | 2.7B | ↑ 2.09% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.6B | ↓ 3.33% |
Total Liabilities | 2.6B | ↓ 4.13% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.5B | ↓ 0.58% |
Total Liabilities | 2.6B | ↑ 0.02% |
FY17 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 133.5M | ↓ 24.47% |
Investing Cash Flow | -240.1M | ↓ 268.63% |
Financing Cash Flow | 598.8M | ↓ 299.01% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 358.5M | ↑ 168.6% |
Investing Cash Flow | -258.5M | ↑ 7.67% |
Financing Cash Flow | -627.3M | ↓ 204.76% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 372.5M | ↑ 3.89% |
Investing Cash Flow | 262.8M | ↓ 201.68% |
Financing Cash Flow | -646.2M | ↑ 3.01% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 354.9M | ↓ 4.73% |
Investing Cash Flow | -136.5M | ↓ 151.91% |
Financing Cash Flow | -202.1M | ↓ 68.72% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 356.4M | ↑ 0.43% |
Investing Cash Flow | -336.2M | ↑ 146.39% |
Financing Cash Flow | 30.1M | ↓ 114.91% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 315.7M | ↓ 11.41% |
Investing Cash Flow | -216.2M | ↓ 35.68% |
Financing Cash Flow | -161.7M | ↓ 636.52% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 63.1M | ↓ 35.55% |
Investing Cash Flow | -37.2M | ↓ 85.61% |
Financing Cash Flow | -112.5M | ↓ 59.03% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 76.6M | ↑ 21.32% |
Investing Cash Flow | -90.9M | ↑ 143.96% |
Financing Cash Flow | 56.0M | ↓ 149.73% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 108.5M | ↑ 41.65% |
Investing Cash Flow | -57.0M | ↓ 37.28% |
Financing Cash Flow | -91.6M | ↓ 263.75% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 67.6M | ↓ 37.69% |
Investing Cash Flow | -31.2M | ↓ 45.32% |
Financing Cash Flow | -13.5M | ↓ 85.24% |
Sell
Neutral
Buy
Sabra Health Care Reit Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Sabra Health Care Reit Inc | 13.17% | 28.5% | 9.91% | -3.2% | -39.32% |
![]() Healthcare Realty Trust Incorporated | -10.33% | -20.12% | -27.91% | -49.82% | -47.52% |
![]() Ventas, Inc. | -3.87% | -2.82% | 1.09% | -2.75% | -23.32% |
![]() Healthpeak Properties, Inc. | -9.67% | -11.53% | -19.25% | -32.64% | -28.23% |
![]() Welltower Inc. | -0.25% | 19.46% | 26.09% | 49.09% | 28.61% |
![]() Omega Healthcare Investors Inc. | 8.43% | 25.32% | 16.31% | 10.26% | 3.25% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Sabra Health Care Reit Inc | 66.84 | NA | 3.15 | 0.31 | -0.04 | 0.01 | 0.09 | 12.73 |
![]() Healthcare Realty Trust Incorporated | 176.7 | NA | 4.67 | -0.65 | -0.04 | 0.0 | 0.08 | 18.85 |
![]() Ventas, Inc. | 192.95 | 192.95 | 2.28 | 0.32 | 0.01 | 0.02 | 0.04 | 24.9 |
![]() Healthpeak Properties, Inc. | 21.07 | 21.07 | 3.19 | 0.47 | 0.08 | 0.01 | 0.06 | 11.95 |
![]() Welltower Inc. | 317.85 | 317.85 | 0.6 | 0.65 | 0.01 | 0.02 | 0.03 | 41.73 |
![]() Omega Healthcare Investors Inc. | 32.53 | 32.53 | 1.13 | 1.08 | 0.06 | 0.02 | 0.08 | 15.04 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Sabra Health Care Reit Inc | Buy | $3.2B | -39.32% | 66.84 | -22.77% |
![]() Healthcare Realty Trust Incorporated | Buy | $5.9B | -47.52% | 176.7 | -13.5% |
![]() Ventas, Inc. | Buy | $17.1B | -23.32% | 192.95 | 1.81% |
![]() Healthpeak Properties, Inc. | Buy | $11.3B | -28.23% | 21.07 | 25.11% |
![]() Welltower Inc. | Buy | $42.9B | 28.61% | 317.85 | 1.91% |
![]() Omega Healthcare Investors Inc. | Hold | $8.4B | 3.25% | 32.53 | 28.58% |
Vanguard Group Inc
BlackRock Inc
Principal Financial Group Inc
State Street Corporation
Bank of New York Mellon Corp
Geode Capital Management, LLC
In the quarter ending September,2023. Sabra Health Care Reit Inc has declared dividend of $0.3
Read Moresabra health care reit, inc. is a self-administered, self-managed realty company that owns and invests in real estate serving the healthcare industry. sabra, a maryland corporation, generates revenues by leasing properties to local, regional and national tenants and operators throughout the united states.
Organization | Sabra Health Care Reit Inc |
Employees | 42 |
CEO | Mr. Richard K. Matros |
Industry | Finance |
Caci International Inc
$13.73
-0.15%
National Health Investors Inc.
$13.73
-0.15%
Patterson Companies, Inc.
$13.73
-0.15%
Blackrock Short Maturity Bond Etf
$13.73
-0.15%
Central Garden & Pet Co
$13.73
-0.15%
Qifu Technology Inc
$13.73
-0.15%
Cubesmart
$13.73
-0.15%
Dlocal Limited
$13.73
-0.15%
Axa Equitable Holdings, Inc.
$13.73
-0.15%